Phase II monotherapy trial of REL-1017 in patients with major depressive disorder
Latest Information Update: 30 Oct 2020
At a glance
- Drugs Esmethadone (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 30 Oct 2020 New trial record
- 27 Oct 2020 According to a Relmada Therapeutics, the company anticipates to start this trial in 1H of 2021 and report result in 4Q of 2021.